Downregulation of doxorubicin-induced myocardial apoptosis accompanies postnatal heart maturation

被引:29
|
作者
Shi, Jianjian [1 ]
Zhang, Lumin [1 ]
Zhang, Yi-Wei [1 ]
Surma, Michelle [1 ]
Payne, R. Mark [1 ,2 ]
Wei, Lei [1 ,2 ]
机构
[1] Indiana Univ, Sch Med, Dept Pediat, Riley Heart Res Ctr,Wells Ctr Pediat Res, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA
关键词
anthracycline; caspase; cardiotoxicity; cardiomyocyte; chemotherapy; PROGENITOR-CELL FUNCTION; CARDIOMYOCYTE APOPTOSIS; SUSCEPTIBILITY; EXPRESSION; FAILURE; INJURY; APAF-1; DEATH; CARDIOTOXICITY; DYSFUNCTION;
D O I
10.1152/ajpheart.00844.2011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Shi J, Zhang L, Zhang YW, Surma M, Payne RM, Wei L. Downregulation of doxorubicin-induced myocardial apoptosis accompanies postnatal heart maturation. Am J Physiol Heart Circ Physiol 302: H1603-H1613, 2012. First published February 10, 2012; doi: 10.1152/ajpheart.00844.2011.-Doxorubicin is a highly effective chemotherapeutic agent used for treating a wide spectrum of tumors, but its usage is limited because of its dose-dependent cardiotoxicity, especially in pediatric patients. Accumulating evidence indicates that caspase-dependent apoptosis contributes to the cardiotoxicity of doxorubicin. However, less attention has been paid to the effects of age on doxorubicin-induced apoptosis signaling in myocardium. This study focused on investigating differential apoptotic sensitivity between neonatal and adult myocardium, in particular, between neonatal and adult cardiomyocytes in vivo. Our results show that caspase-3 activity in normal mouse hearts decreased by >= 20-fold within the first 3 wk after birth, associated with a rapid downregulation in the expression of key proapoptotic proteins in intrinsic and extrinsic pathways. This rapid downregulation of caspase-3 activity was confirmed by immunostaining for cleaved caspase-3 and terminal deoxynucleotidyl transferase dUTP-mediated nick-end label staining. Doxorubicin treatment induced a dose-dependent increase in caspase-3 activity and apoptosis in neonatal mouse hearts, and both caspase-8 and caspase-9 activations were involved. Using transgenic mice with a nuclear localized LacZ reporter gene to label cardiomyocytes in vivo, we observed a fourfold higher level of doxorubicin-induced cardiomyocyte apoptosis in 1-wk-old mice compared with that in 3-wk-old mice. This study points to a major difference in apoptotic signaling in doxorubicin cardiotoxicity between neonatal and adult mouse hearts and reveals a critical transition from high to low susceptibility to doxorubicin-induced apoptosis during postnatal heart maturation.
引用
收藏
页码:H1603 / H1613
页数:11
相关论文
共 50 条
  • [41] Caspase inhibition switches doxorubicin-induced apoptosis to senescence
    Rebbaa, A
    Zheng, X
    Chou, PM
    Mirkin, BL
    ONCOGENE, 2003, 22 (18) : 2805 - 2811
  • [42] Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes
    Bar-Joseph, Hadas
    Ben-Aharon, Irit
    Rizel, Shulamith
    Stemmer, Salomon M.
    Tzabari, Moran
    Shalgi, Ruth
    REPRODUCTIVE TOXICOLOGY, 2010, 30 (04) : 566 - 572
  • [43] Sarcoplasmic mediated apoptosis and gender difference in doxorubicin-induced apoptosis in vivo
    Jang, YMC
    Kendaiah, S
    Phillips, T
    Leeuwenburgh, C
    FASEB JOURNAL, 2004, 18 (05): : A1031 - A1031
  • [44] Myocardial strain analysis in a doxorubicin-induced cardiomyopathy model
    Pfegari, Elena
    Di Salvo, Giovanni
    Castaldi, Biagio
    Vitelli, Maria Redenta
    Rodolico, Gabriella
    Golinot, Paolo
    Calabro, Raffaele
    Rossi, Francesco
    Berrino, Liberato
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2008, 34 (03): : 370 - 378
  • [45] Endogenous PACAP attenuated doxorubicin-induced myocardial damage
    Mori, Hiroyoshi
    Nakamachi, Tomoya
    Ohtaki, Hirokazu
    Hasegawa, Fumio
    Yofu, Sachiko
    Suzuki, Hiroshi
    Takeyama, Youichi
    Shintani, Norihito
    Hashimoto, Hitoshi
    Baba, Akemichi
    Shioda, Seiji
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2010, 42 (03) : 295 - 295
  • [46] ABSENCE OF ACUTE DOXORUBICIN-INDUCED MYOCARDIAL MITOCHONDRIAL DYSFUNCTION
    PELIKAN, PCD
    GERSTENBLITH, G
    VANDEGAER, KM
    JACOBUS, WE
    CLINICAL RESEARCH, 1985, 33 (02): : A217 - A217
  • [47] Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy
    Hamed, Saher
    Barshack, Iris
    Luboshits, Galia
    Wexter, Dov
    Deutsch, Varda
    Keren, Gad
    George, Jacob
    EUROPEAN HEART JOURNAL, 2006, 27 (15) : 1876 - 1883
  • [48] 16 Myocardial Expression of Mutant P53 Protects Against Doxorubicin-Induced Cardiomyocyte Apoptosis and Preserves Heart Function.
    W Zhu
    L J Field
    Herman B Wells
    Pediatric Research, 2006, 60 : 493 - 493
  • [49] Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis
    Kuzu, Muslum
    Kandemir, Fatih Mehmet
    Yildirim, Serkan
    Kucukler, Sefa
    Caglayan, Cuneyt
    Turk, Erdinc
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 : 443 - 453
  • [50] Neuregulin-1 Alleviated Doxorubicin-Induced Downregulation of Cardiac Troponin I and Cardiac Troponin T in the Heart
    Bian, Yun
    Sun, Maoyun
    Silver, Marcy
    Ho, Kalon K.
    Marchionni, Mark A.
    Caggiano, Anthony
    Kang, Peter M.
    Morgan, James P.
    Yan, Xinhua
    CIRCULATION RESEARCH, 2008, 103 (05) : E68 - E69